Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MR-107A-02 Dose Response in Post Surgical Dental Pain
NCT05317312Phase 2Completed
- Sponsor
- Viatris
- Start
- Mar 2022
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MR-107A-02 in postoperative pain, sponsored by Viatris. Started Mar 2022; status: completed.
02
Drugs
MR-107A-02
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05317312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05317312.